WallStreetZenWallStreetZen

NASDAQ: HRTX
Heron Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HRTX past revenue growth

How has HRTX's revenue growth performed historically?
Company
17.99%
Industry
145.22%
Market
17.76%
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HRTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HRTX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HRTX earnings and revenue history

Current Revenue
$127.0M
Current Earnings
-$110.6M
Current Profit Margin
-87%

HRTX Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when HRTX announces earnings.

HRTX Return on Assets

Current Company
-50.6%
Current Industry
2.9%
HRTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HRTX Return on Capital Employed

Current Company
-77.06%
Current Industry
19.5%
HRTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HRTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HRTX$127.04M-$107.16M-$110.56M+10.40%N/A
CRBP$0.00-$41.04M-$44.60M-100.00%N/A
PEPG$0.00-$77.37M-$78.63MN/AN/A
MNMD$0.00-$92.57M-$95.73MN/AN/A
ADCT$69.56M-$151.36M-$240.05M+127.56%N/A
View Top Biotech Stocks

HRTX earnings dates

Next earnings date
Jun 13, 2024

Heron Therapeutics Earnings & Revenue FAQ

What were HRTX's earnings last quarter?

On Invalid Date, Heron Therapeutics (NASDAQ: HRTX) reported Q4 2023 earnings per share (EPS) of -$0.05, up 61.54% year over year. Total Heron Therapeutics earnings for the quarter were -$10.72 million. In the same quarter last year, Heron Therapeutics's earnings per share (EPS) was -$0.13.

If you're new to stock investing, here's how to buy Heron Therapeutics stock.

What was HRTX's earnings growth in the past year?

As of Q2 2024, Heron Therapeutics's earnings has grown year over year. Heron Therapeutics's earnings in the past year totalled -$110.56 million.

What is HRTX's earnings date?

Heron Therapeutics's earnings date is Invalid Date. Add HRTX to your watchlist to be reminded of HRTX's next earnings announcement.

What was HRTX's revenue last quarter?

On Invalid Date, Heron Therapeutics (NASDAQ: HRTX) reported Q4 2023 revenue of $34.23 million up 14% year over year. In the same quarter last year, Heron Therapeutics's revenue was $30.03 million.

What was HRTX's revenue growth in the past year?

As of Q2 2024, Heron Therapeutics's revenue has grown 17.99% year over year. This is 127.23 percentage points lower than the US Biotechnology industry revenue growth rate of 145.22%. Heron Therapeutics's revenue in the past year totalled $127.04 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.